- ►annals.org [PDF] L Marchionni, RF Wilson, AC Wolff, S … - Annals of Internal Medicine, 2008 - Am Coll Physicians Purpose: To summarize evidence on the validity and utility of 3 gene
expression–based prognostic breast cancer tests: Oncotype DX (Genomic Health,
Redwood City, California), MammaPrint (Agendia BV, Amsterdam, the ... Cited by 38 - Related articles - BL Direct - All 4 versions
A Tables - Ann Intern Med, 2008 - assets0.pubget.com Purpose: To summarize evidence on the validity and utility of 3 gene
expression–based prognostic breast cancer tests: Oncotype DX (Genomic Health,
Redwood City, California), MammaPrint (Agendia BV, Amsterdam, the ... Related articles - View as HTML - All 2 versions
[CITATION] Systematic Review: Gene Expression Profiling Assays in Early-Stage Breast Cancer.
L Marchionni, RF Wilson, SS Marinopoulos, … - Evid Rep Technol Assess (Full Rep), 2007 - ahcpr.gov Prepared for: Agency for Healthcare Research and Quality US Department of Health
and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov ...
Prepared by: The Johns Hopkins University Evidence-based Practice Center, ... Cited by 9 - Related articles - View as HTML - All 4 versions
- ►jcojournal.org JA Sparano, S Paik - Journal of Clinical Oncology, 2008 - jcojournal.org Several multigene markers that predict relapse more accurately than classical
clinicopathologic features have been developed. The 21-gene assay was developed
specifically for patients with estrogen receptor (ER)–positive breast ... Cited by 53 - Related articles - All 5 versions
C Affected, S Blue, PPO Medicare, T Blue - bcbswny.com The following protocol contains medical necessity criteria for Assays of Genetic
Expression in Tumor Tissue as a Technique to Determine Prognosis In Patients
With Breast Cancer services rendered on or after July 1, 2007 for BlueCross ... Related articles - View as HTML - All 2 versions
- ►clinchem.org M Cronin, C Sangli, ML Liu, M Pho, D Dutta, … - Clinical Chemistry, 2007 - Am Assoc Clin Chem Background: Oncotype DX TM is a clinically validated, high-complexity,
multianalyte reverse transcription–PCR genomic test that predicts the
likelihood of breast cancer recurrence in early-stage, node-negative, ... Cited by 24 - Related articles - BL Direct - All 4 versions
E Leich, EM Hartmann, C Burek, G Ott, A … - Apmis, 2007 - interscience.wiley.com Gene expression profiling is a powerful tool to uncover complex molecular
networks in cancer and, specifically, in malignant lymphomas. Within diffuse
large B-cell lymphomas (DLBCL), two major molecular subtypes, the activated ... Cited by 10 - Related articles - BL Direct - All 6 versions
M Cianfrocca, W Gradishar - CA: A Cancer Journal for Clinicians, 2009 - Am Cancer Soc Traditionally, pathologic determinations of tumor size, lymph node status,
endocrine receptor status, and human epidermal growth factor receptor 2 (HER2)
status have driven prognostic predictions and adjuvant therapy ... Related articles - All 3 versions
